News

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

Fundsmith, an investment management firm based in London, has released its second-quarter 2026 investor letter for its “Fundsmith Equity Fund.” A copy of the letter can be downloaded here. The Fund returned -2.9% in the first half of 2026, underperforming the MSCI World Index by 14.1 percentage points, driven by challenges from a momentum-driven market […]

From commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over the last six months, the industry’s 13.5% return has topped the S&P 500 by 8.6 percentage points.

The latest trading day saw Veeva Systems (VEEV) settling at $201.56, representing a -3.05% change from its previous close.

Veeva Systems stock has fallen 44.0% over the past five years, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate suggests the current US$186.24 share price sits at a meaningful discount. This creates a clear tension between past returns and what the valuation work implies today. The 44.0% decline over five years means long term shareholders have seen substantial value eroded, so any current valuation upside case needs to be weighed against that track record. Expectations for...

Veeva Systems recently raised its fiscal 2027 revenue guidance to about US$3.65 billion and adjusted EPS outlook to roughly US$9.05, following fiscal Q1 2027 results that exceeded its own guidance and showed stronger profitability helped by expanding AI-driven offerings. This combination of upgraded full-year targets and growing AI-enabled products has sharpened investor focus on how Veeva’s business model may be evolving toward higher-margin, software-driven growth. With Veeva lifting its...

Veeva Systems is scheduled to post its second-quarter results soon, and analysts project a double-digit earnings growth.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

In the closing of the recent trading day, Veeva Systems (VEEV) stood at $179.58, denoting a -2.69% move from the preceding trading day.

According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

Investing.com -- Cash balances of U.S. companies swelled in the first quarter of 2026, with most companies aggressively deploying money back into their businesses, according to Morgan Stanley.

Veeva Systems (VEEV) concluded the recent trading session at $195.38, signifying a -1.01% move from its prior day's close.

VEEV's strong Q1, growing Vault CRM migrations and AI expansion support growth, though life sciences CRM market saturation poses risks.

The latest trading day saw Veeva Systems (VEEV) settling at $193.09, representing a -1.89% change from its previous close.

Veeva Systems (NYSE:VEEV) has introduced Veeva EHS, a new environmental, health, and safety application within its Quality Cloud suite. The application is designed to provide an automated, unified platform for managing EHS processes across manufacturing and testing operations. An early adopter rollout is planned for August 2026, targeting life sciences and manufacturing customers that rely on Veeva's quality and compliance tools. For investors following Veeva Systems, Veeva EHS extends the...

Veeva Systems has gotten torched over the last six months - since January 2026, its stock price has dropped 21.7% to $187.94 per share. This may have investors wondering how to approach the situation.

Veeva Systems (VEEV) concluded the recent trading session at $188.17, signifying a -2.15% move from its prior day's close.

Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.

Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Brown Advisory, an investment management company, released its “Brown Large-Cap Growth Strategy” for the first-quarter 2026 investor letter. A copy of the letter is available to download here. The Brown Advisory Large-Cap Growth Strategy experienced a decline in the first quarter of 2026, modestly trailing the Russell 1000 Growth Index. Despite negative absolute returns amidst volatility, […]

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Veeva Systems Inc. (NYSE:VEEV) was added to the S&P 500 in early May and thus appears on our list of the 10 stocks that were added to the S&P 500 index recently. In the past week, Veeva Systems Inc. (NYSE:VEEV) has gained over 11.5% following the acquisition of Copli and the launch of the AI-driven […]

VEEV expands its AI push with Copli acquisition and Falcon MLR launch, aiming to speed life sciences content reviews and boost Commercial Cloud.

Veeva Systems Inc. (NYSE:VEEV) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds. On June 23, Veeva Systems Inc. (NYSE:VEEV) announced that it acquired Copli and launched Veeva Falcon MLR. It made the agentic medical, legal, and regulatory content-review platform available immediately. The firm said Veeva Falcon MLR automates […]

If you are wondering whether Veeva Systems stock offers good value at its current price, it can help to step back from the headlines and look at how different valuation methods compare. The stock last closed at US$171.36, with recent moves including an 11.8% gain over the past week and an 8.1% gain over the past month. Year to date the price is down 21.9% and the 1 year return is down 39.5%. These mixed returns sit against a backdrop where investors are paying closer attention to Veeva...

Earlier this week, Veeva Systems expanded its Quality Cloud with the launch of Veeva EHS and advanced its AI transition through acquisitions like Copli, while reporting double-digit revenue growth and raising its full-year outlook. Together, these moves deepen Veeva’s role in life sciences workflows by integrating AI-driven automation across compliance, safety, and content review, potentially reshaping how customers manage risk and regulatory complexity. We’ll now examine how the launch of...

VEEV's Veeva EHS expands Quality Cloud with automated risk, compliance and safety workflows, aiming to replace legacy systems with a unified platform.

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.